fbpx
February 1, 2021

Views on Ethical Issues Shifting in Family, Internal Medicine Views on Ethical Issues Shifting in Family, Internal Medicine

Internal medicine physicians’ and family physicians’ attitudes have changed in recent years on several ethical issues, according to the Medscape Internal Medicine Ethics Report 2020 and […]
February 1, 2021

One Third of Healthcare Workers Leery of Getting COVID Vaccine One Third of Healthcare Workers Leery of Getting COVID Vaccine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Nearly 60% of those working in a large healthcare system expressed their […]
February 1, 2021

Physicians Face Potential Peril With Leftover Vaccine Doses Physicians Face Potential Peril With Leftover Vaccine Doses

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A Texas judge last week dismissed a theft charge against an emergency […]
February 1, 2021

Nivolumab Improves Survival in Relapsed Mesothelioma Nivolumab Improves Survival in Relapsed Mesothelioma

In the first ever placebo-controlled phase 3 trial in patients with relapsed mesothelioma, immunotherapy with nivolumab (Opdivo) significantly improved both overall survival (OS) and progression-free survival […]
February 1, 2021

Gestational Diabetes Carries CVD Risk Years Later Gestational Diabetes Carries CVD Risk Years Later

Erica P. Gunderson, PhD Women who’ve had gestational diabetes are 40% more likely to develop coronary artery calcification later in life than those who have never […]
February 1, 2021

CVD Remains Leading Killer, but COVID’s Impact Still Unclear CVD Remains Leading Killer, but COVID’s Impact Still Unclear

Cardiovascular disease (CVD) remains the leading cause of death in the United States and around the world, according to the annual statistical update on heart disease […]
February 1, 2021

‘Astonishing’ 4-Year Survival in NSCLC With Pembro+Chemo ‘Astonishing’ 4-Year Survival in NSCLC With Pembro+Chemo

Lung cancer experts have been rejoicing over new longer-term results that continue to show the combination of immunotherapy and chemotherapy doubles survival compared with chemotherapy alone. […]
February 1, 2021

Lasting Benefit With Nivo Plus Ipi in Advanced Liver Cancer Lasting Benefit With Nivo Plus Ipi in Advanced Liver Cancer

Long-term follow-up data show a continued benefit for patients with advanced hepatocellular carcinoma (HCC) treated with nivolumab and ipilimumab after disease progression on sorafenib, according to […]
February 1, 2021

Newer iPhones Disable Implanted Defibrillators Newer iPhones Disable Implanted Defibrillators

Patients with an implantable cardioverter defibrillator (ICD) should be warned that some newer models of smartphones equipped with magnets, such as the iPhone 12, can disable their […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860861862863864865866867868869870871872873874875876877878879880881882883884885886887888889890891892893894895896897898899900901902903904905906907908909910911912913914915916917918919920921922923924925926927928929930931932933934935936937938939940941942943944945946947948949950951952953954955956957958959960961962963964965966967968969970971972973974975976977978979980981982983984985986987988989990991992993994995996997998999100010011002100310041005100610071008100910101011101210131014101510161017101810191020102110221023102410251026102710281029103010311032103310341035103610371038103910401041104210431044104510461047104810491050105110521053105410551056105710581059106010611062106310641065106610671068106910701071107210731074107510761077
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0